Immuneering Corp. (IMRX)

4.93 -0.07 (-1.40%) USD  |  NASDAQ  |  Mar 03, 11:29
More

Immuneering Rent and Landing Expense (Quarterly)

Rent and Landing Expense (Quarterly) Chart

View Rent and Landing Expense (Quarterly) for IMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Rent and Landing Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Rent and Landing Expense (Quarterly) Range, Past 5 Years

View Rent and Landing Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Rent and Landing Expense (Quarterly) Benchmarks

View Rent and Landing Expense (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. --
Verastem, Inc. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. --
Moderna, Inc. --